Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2009-01-08 17:24:05 UTC |
---|
Update Date | 2022-03-07 02:51:11 UTC |
---|
HMDB ID | HMDB0011533 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | MG(0:0/16:0/0:0) |
---|
Description | MG(0:0/16:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed 'alpha-monoacylglycerols', while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. |
---|
Structure | [H]C(CO)(CO)OC(=O)CCCCCCCCCCCCCCC InChI=1S/C19H38O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(22)23-18(16-20)17-21/h18,20-21H,2-17H2,1H3 |
---|
Synonyms | Value | Source |
---|
1,3-Dihydroxypropan-2-yl palmitate | ChEBI | 2-Hexadecanoylglycerol | ChEBI | 2-Monopalmitin | ChEBI | 2-Monopalmitoylglycerol | ChEBI | 2-O-Palmitoylglycerol | ChEBI | MG (0:0/16:0/0:0) | ChEBI | 1,3-Dihydroxypropan-2-yl palmitic acid | Generator | 1-Monoacylglyceride | HMDB | 1-Monoacylglycerol | HMDB | 2-Hexadecanoyl-rac-glycerol | HMDB | 2-Palmitoyl-glycerol | HMDB | b-Monoacylglycerol | HMDB | beta-Monoacylglycerol | HMDB | MAG(0:0/16:0) | HMDB | MAG(16:0) | HMDB | MG(0:0/16:0) | HMDB | MG(16:0) | HMDB | 2-Palm-GL | HMDB | 2-Palmitoylglycerol | MeSH |
|
---|
Chemical Formula | C19H38O4 |
---|
Average Molecular Weight | 330.5026 |
---|
Monoisotopic Molecular Weight | 330.277009704 |
---|
IUPAC Name | 1,3-dihydroxypropan-2-yl hexadecanoate |
---|
Traditional Name | 1,3-dihydroxypropan-2-yl hexadecanoate |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H]C(CO)(CO)OC(=O)CCCCCCCCCCCCCCC |
---|
InChI Identifier | InChI=1S/C19H38O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(22)23-18(16-20)17-21/h18,20-21H,2-17H2,1H3 |
---|
InChI Key | BBNYCLAREVXOSG-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 2-monoacylglycerols. These are monoacylglycerols containing a glycerol acylated at the 2-position. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Glycerolipids |
---|
Sub Class | Monoradylglycerols |
---|
Direct Parent | 2-monoacylglycerols |
---|
Alternative Parents | |
---|
Substituents | - 2-acyl-sn-glycerol
- Fatty acid ester
- Fatty acyl
- Carboxylic acid ester
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Primary alcohol
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- Glycerolipid Metabolism (HMDB: HMDB0011533)
- Triacylglycerol Degradation TG(16:0/16:0/16:0) (PathBank: SMP0012468)
- Triacylglycerol Degradation TG(16:0/16:0/18:0) (PathBank: SMP0012469)
- Triacylglycerol Degradation TG(16:0/16:0/18:1(9Z)) (PathBank: SMP0012470)
- Triacylglycerol Degradation TG(16:0/16:0/18:1(11Z)) (PathBank: SMP0012471)
- Triacylglycerol Degradation TG(16:0/16:0/18:2(9Z,12Z)) (PathBank: SMP0012472)
- Triacylglycerol Degradation TG(16:0/16:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0012473)
- Triacylglycerol Degradation TG(16:0/16:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0012474)
- Triacylglycerol Degradation TG(16:0/16:0/20:0) (PathBank: SMP0012475)
- Triacylglycerol Degradation TG(16:0/16:0/20:1(11Z)) (PathBank: SMP0012476)
- Triacylglycerol Degradation TG(16:0/16:0/20:1(13Z)) (PathBank: SMP0012477)
- Triacylglycerol Degradation TG(16:0/16:0/22:0) (PathBank: SMP0012478)
- Triacylglycerol Degradation TG(16:0/16:0/22:1(13Z)) (PathBank: SMP0012479)
- Triacylglycerol Degradation TG(18:0/16:0/16:0) (PathBank: SMP0012612)
- Triacylglycerol Degradation TG(18:0/16:0/18:0) (PathBank: SMP0012613)
- Triacylglycerol Degradation TG(18:0/16:0/18:1(9Z)) (PathBank: SMP0012614)
- Triacylglycerol Degradation TG(18:0/16:0/18:1(11Z)) (PathBank: SMP0012615)
- Triacylglycerol Degradation TG(18:0/16:0/18:2(9Z,12Z)) (PathBank: SMP0012616)
- Triacylglycerol Degradation TG(18:0/16:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0012617)
- Triacylglycerol Degradation TG(18:0/16:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0012618)
- Triacylglycerol Degradation TG(18:0/16:0/20:0) (PathBank: SMP0012619)
- Triacylglycerol Degradation TG(18:0/16:0/20:1(11Z)) (PathBank: SMP0012620)
- Triacylglycerol Degradation TG(18:0/16:0/20:1(13Z)) (PathBank: SMP0012621)
- Triacylglycerol Degradation TG(18:0/16:0/22:0) (PathBank: SMP0012622)
- Triacylglycerol Degradation TG(18:0/16:0/22:1(13Z)) (PathBank: SMP0012623)
- Triacylglycerol Degradation TG(18:1(9Z)/16:0/16:0) (PathBank: SMP0012756)
- Triacylglycerol Degradation TG(18:1(9Z)/16:0/18:0) (PathBank: SMP0012757)
- Triacylglycerol Degradation TG(18:1(9Z)/16:0/18:1(9Z)) (PathBank: SMP0012758)
- Triacylglycerol Degradation TG(18:1(9Z)/16:0/18:1(11Z)) (PathBank: SMP0012759)
- Triacylglycerol Degradation TG(18:1(9Z)/16:0/18:2(9Z,12Z)) (PathBank: SMP0012760)
- Triacylglycerol Degradation TG(18:1(9Z)/16:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0012761)
- Triacylglycerol Degradation TG(18:1(9Z)/16:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0012762)
- Triacylglycerol Degradation TG(18:1(9Z)/16:0/20:0) (PathBank: SMP0012763)
- Triacylglycerol Degradation TG(18:1(9Z)/16:0/20:1(11Z)) (PathBank: SMP0012764)
- Triacylglycerol Degradation TG(18:1(9Z)/16:0/20:1(13Z)) (PathBank: SMP0012765)
- Triacylglycerol Degradation TG(18:1(9Z)/16:0/22:0) (PathBank: SMP0012766)
- Triacylglycerol Degradation TG(18:1(9Z)/16:0/22:1(13Z)) (PathBank: SMP0012767)
- Triacylglycerol Degradation TG(18:1(11Z)/16:0/16:0) (PathBank: SMP0012900)
- Triacylglycerol Degradation TG(18:1(11Z)/16:0/18:0) (PathBank: SMP0012901)
- Triacylglycerol Degradation TG(18:1(11Z)/16:0/18:1(9Z)) (PathBank: SMP0012902)
- Triacylglycerol Degradation TG(18:1(11Z)/16:0/18:1(11Z)) (PathBank: SMP0012903)
- Triacylglycerol Degradation TG(18:1(11Z)/16:0/18:2(9Z,12Z)) (PathBank: SMP0012904)
- Triacylglycerol Degradation TG(18:1(11Z)/16:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0012905)
- Triacylglycerol Degradation TG(18:1(11Z)/16:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0012906)
- Triacylglycerol Degradation TG(18:1(11Z)/16:0/20:0) (PathBank: SMP0012907)
- Triacylglycerol Degradation TG(18:1(11Z)/16:0/20:1(11Z)) (PathBank: SMP0012908)
- Triacylglycerol Degradation TG(18:1(11Z)/16:0/20:1(13Z)) (PathBank: SMP0012909)
- Triacylglycerol Degradation TG(18:1(11Z)/16:0/22:0) (PathBank: SMP0012910)
- Triacylglycerol Degradation TG(18:1(11Z)/16:0/22:1(13Z)) (PathBank: SMP0012911)
- Triacylglycerol Degradation TG(18:2(9Z,12Z)/16:0/16:0) (PathBank: SMP0013044)
- Triacylglycerol Degradation TG(18:2(9Z,12Z)/16:0/18:0) (PathBank: SMP0013045)
- Triacylglycerol Degradation TG(18:2(9Z,12Z)/16:0/18:1(9Z)) (PathBank: SMP0013046)
- Triacylglycerol Degradation TG(18:2(9Z,12Z)/16:0/18:1(11Z)) (PathBank: SMP0013047)
- Triacylglycerol Degradation TG(18:2(9Z,12Z)/16:0/18:2(9Z,12Z)) (PathBank: SMP0013048)
- Triacylglycerol Degradation TG(18:2(9Z,12Z)/16:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0013049)
- Triacylglycerol Degradation TG(18:2(9Z,12Z)/16:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0013050)
- Triacylglycerol Degradation TG(18:2(9Z,12Z)/16:0/20:0) (PathBank: SMP0013051)
- Triacylglycerol Degradation TG(18:2(9Z,12Z)/16:0/20:1(11Z)) (PathBank: SMP0013052)
- Triacylglycerol Degradation TG(18:2(9Z,12Z)/16:0/20:1(13Z)) (PathBank: SMP0013053)
- Triacylglycerol Degradation TG(18:2(9Z,12Z)/16:0/22:0) (PathBank: SMP0013054)
- Triacylglycerol Degradation TG(18:2(9Z,12Z)/16:0/22:1(13Z)) (PathBank: SMP0013055)
- Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/16:0/16:0) (PathBank: SMP0013188)
- Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/16:0/18:0) (PathBank: SMP0013189)
- Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/16:0/18:1(9Z)) (PathBank: SMP0013190)
- Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/16:0/18:1(11Z)) (PathBank: SMP0013191)
- Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/16:0/18:2(9Z,12Z)) (PathBank: SMP0013192)
- Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/16:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0013193)
- Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/16:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0013194)
- Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/16:0/20:0) (PathBank: SMP0013195)
- Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/16:0/20:1(11Z)) (PathBank: SMP0013196)
- Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/16:0/20:1(13Z)) (PathBank: SMP0013197)
- Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/16:0/22:0) (PathBank: SMP0013198)
- Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/16:0/22:1(13Z)) (PathBank: SMP0013199)
- Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/16:0/16:0) (PathBank: SMP0013332)
- Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/16:0/18:0) (PathBank: SMP0013333)
- Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/16:0/18:1(9Z)) (PathBank: SMP0013334)
- Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/16:0/18:1(11Z)) (PathBank: SMP0013335)
- Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/16:0/18:2(9Z,12Z)) (PathBank: SMP0013336)
- Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/16:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0013337)
- Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/16:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0013338)
- Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/16:0/20:0) (PathBank: SMP0013339)
- Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/16:0/20:1(11Z)) (PathBank: SMP0013340)
- Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/16:0/20:1(13Z)) (PathBank: SMP0013341)
- Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/16:0/22:0) (PathBank: SMP0013342)
- Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/16:0/22:1(13Z)) (PathBank: SMP0013343)
- Triacylglycerol Degradation TG(20:0/16:0/16:0) (PathBank: SMP0013473)
- Triacylglycerol Degradation TG(20:0/16:0/18:0) (PathBank: SMP0013474)
- Triacylglycerol Degradation TG(20:0/16:0/18:1(9Z)) (PathBank: SMP0013475)
- Triacylglycerol Degradation TG(20:0/16:0/18:1(11Z)) (PathBank: SMP0013476)
- Triacylglycerol Degradation TG(20:0/16:0/18:2(9Z,12Z)) (PathBank: SMP0013477)
- Triacylglycerol Degradation TG(20:0/16:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0013478)
- Triacylglycerol Degradation TG(20:0/16:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0013479)
- Triacylglycerol Degradation TG(20:0/16:0/20:0) (PathBank: SMP0013480)
- Triacylglycerol Degradation TG(20:0/16:0/20:1(11Z)) (PathBank: SMP0013481)
- Triacylglycerol Degradation TG(20:0/16:0/20:1(13Z)) (PathBank: SMP0013482)
- Triacylglycerol Degradation TG(20:0/16:0/22:0) (PathBank: SMP0013483)
- Triacylglycerol Degradation TG(20:0/16:0/22:1(13Z)) (PathBank: SMP0013484)
- Triacylglycerol Degradation TG(20:1(11Z)/16:0/16:0) (PathBank: SMP0013617)
- Triacylglycerol Degradation TG(20:1(11Z)/16:0/18:0) (PathBank: SMP0013618)
- Triacylglycerol Degradation TG(20:1(11Z)/16:0/18:1(9Z)) (PathBank: SMP0013619)
- Triacylglycerol Degradation TG(20:1(11Z)/16:0/18:1(11Z)) (PathBank: SMP0013620)
- Triacylglycerol Degradation TG(20:1(11Z)/16:0/18:2(9Z,12Z)) (PathBank: SMP0013621)
- Triacylglycerol Degradation TG(20:1(11Z)/16:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0013622)
- Triacylglycerol Degradation TG(20:1(11Z)/16:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0013623)
- Triacylglycerol Degradation TG(20:1(11Z)/16:0/20:0) (PathBank: SMP0013624)
- Triacylglycerol Degradation TG(20:1(11Z)/16:0/20:1(11Z)) (PathBank: SMP0013625)
- Triacylglycerol Degradation TG(20:1(11Z)/16:0/20:1(13Z)) (PathBank: SMP0013626)
- Triacylglycerol Degradation TG(20:1(11Z)/16:0/22:0) (PathBank: SMP0013627)
- Triacylglycerol Degradation TG(20:1(11Z)/16:0/22:1(13Z)) (PathBank: SMP0013628)
- Triacylglycerol Degradation TG(20:1(13Z)/16:0/16:0) (PathBank: SMP0013762)
- Triacylglycerol Degradation TG(20:1(13Z)/16:0/18:0) (PathBank: SMP0013763)
- Triacylglycerol Degradation TG(20:1(13Z)/16:0/18:1(9Z)) (PathBank: SMP0013764)
- Triacylglycerol Degradation TG(20:1(13Z)/16:0/18:1(11Z)) (PathBank: SMP0013765)
- Triacylglycerol Degradation TG(20:1(13Z)/16:0/18:2(9Z,12Z)) (PathBank: SMP0013766)
- Triacylglycerol Degradation TG(20:1(13Z)/16:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0013767)
- Triacylglycerol Degradation TG(20:1(13Z)/16:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0013768)
- Triacylglycerol Degradation TG(20:1(13Z)/16:0/20:0) (PathBank: SMP0013769)
- Triacylglycerol Degradation TG(20:1(13Z)/16:0/20:1(11Z)) (PathBank: SMP0013770)
- Triacylglycerol Degradation TG(20:1(13Z)/16:0/20:1(13Z)) (PathBank: SMP0013771)
- Triacylglycerol Degradation TG(20:1(13Z)/16:0/22:0) (PathBank: SMP0013772)
- Triacylglycerol Degradation TG(20:1(13Z)/16:0/22:1(13Z)) (PathBank: SMP0013773)
- Triacylglycerol Degradation TG(22:0/16:0/16:0) (PathBank: SMP0013907)
- Triacylglycerol Degradation TG(22:0/16:0/18:0) (PathBank: SMP0013908)
- Triacylglycerol Degradation TG(22:0/16:0/18:1(9Z)) (PathBank: SMP0013909)
- Triacylglycerol Degradation TG(22:0/16:0/18:1(11Z)) (PathBank: SMP0013910)
- Triacylglycerol Degradation TG(22:0/16:0/18:2(9Z,12Z)) (PathBank: SMP0013911)
- Triacylglycerol Degradation TG(22:0/16:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0013912)
- Triacylglycerol Degradation TG(22:0/16:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0013913)
- Triacylglycerol Degradation TG(22:0/16:0/20:0) (PathBank: SMP0013914)
- Triacylglycerol Degradation TG(22:0/16:0/20:1(11Z)) (PathBank: SMP0013915)
- Triacylglycerol Degradation TG(22:0/16:0/20:1(13Z)) (PathBank: SMP0013916)
- Triacylglycerol Degradation TG(22:0/16:0/22:0) (PathBank: SMP0013917)
- Triacylglycerol Degradation TG(22:0/16:0/22:1(13Z)) (PathBank: SMP0013918)
- Triacylglycerol Degradation TG(22:1(13Z)/16:0/16:0) (PathBank: SMP0014053)
- Triacylglycerol Degradation TG(22:1(13Z)/16:0/18:0) (PathBank: SMP0014054)
- Triacylglycerol Degradation TG(22:1(13Z)/16:0/18:1(9Z)) (PathBank: SMP0014055)
- Triacylglycerol Degradation TG(22:1(13Z)/16:0/18:1(11Z)) (PathBank: SMP0014056)
- Triacylglycerol Degradation TG(22:1(13Z)/16:0/18:2(9Z,12Z)) (PathBank: SMP0014057)
- Triacylglycerol Degradation TG(22:1(13Z)/16:0/18:3(6Z,9Z,12Z)) (PathBank: SMP0014058)
- Triacylglycerol Degradation TG(22:1(13Z)/16:0/18:3(9Z,12Z,15Z)) (PathBank: SMP0014059)
- Triacylglycerol Degradation TG(22:1(13Z)/16:0/20:0) (PathBank: SMP0014060)
- Triacylglycerol Degradation TG(22:1(13Z)/16:0/20:1(11Z)) (PathBank: SMP0014061)
- Triacylglycerol Degradation TG(22:1(13Z)/16:0/20:1(13Z)) (PathBank: SMP0014062)
- Triacylglycerol Degradation TG(22:1(13Z)/16:0/22:0) (PathBank: SMP0014063)
- Triacylglycerol Degradation TG(22:1(13Z)/16:0/22:1(13Z)) (PathBank: SMP0014064)
- D-glyceric acidura (HMDB: HMDB0011533)
Disease pathway Chemical reactionBiochemical processCellular process |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - MG(0:0/16:0/0:0) GC-EI-TOF (Non-derivatized) | splash10-0fba-1920000000-134607514f54b5fa383a | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - MG(0:0/16:0/0:0) GC-EI-TOF (Non-derivatized) | splash10-0fba-1920000000-134607514f54b5fa383a | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - MG(0:0/16:0/0:0) GC-MS (2 TMS) - 70eV, Positive | splash10-0fy9-8690000000-42e670eb7d2b93c2cf13 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - MG(0:0/16:0/0:0) GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) LC-ESI-QTOF 35V, positive-QTOF | splash10-0abd-9201000000-13c26a3dfbe9c2c0ee82 | 2020-07-21 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) Orbitrap 0V, positive-QTOF | splash10-001i-0009000000-3fbc80e8b1a6c4769b57 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) n/a 23V, positive-QTOF | splash10-03di-0009000000-ab66c5fcbc1ccb42abd0 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) n/a 23V, positive-QTOF | splash10-0a4i-2590000000-fbd516b957b730aa1e61 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) n/a 23V, positive-QTOF | splash10-014i-9000000000-fb41d95361a6747c1394 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) Orbitrap 9V, positive-QTOF | splash10-03di-3009000000-1461fc327f550f36fd64 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) Orbitrap 11V, positive-QTOF | splash10-08fr-9105000000-5ff0ac490f9e9eb2fd3a | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) Orbitrap 13V, positive-QTOF | splash10-0ab9-9101000000-543e82e44e10c0bafe1b | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) Orbitrap 16V, positive-QTOF | splash10-0a4i-9000000000-42345c34104efaffa9e5 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) Orbitrap 18V, positive-QTOF | splash10-0a4i-9000000000-10f9ae2324888d282fe8 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) Orbitrap 20V, positive-QTOF | splash10-0a4i-9000000000-168d6d9e105e242d5381 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) Orbitrap 24V, positive-QTOF | splash10-0a4i-9000000000-788ea5a75eccdebbb706 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) Orbitrap 30V, positive-QTOF | splash10-0a4i-9000000000-f5d8bcb715bb7c4eec96 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) Orbitrap 36V, positive-QTOF | splash10-0a4i-9000000000-bebf6a01d91a3cefd039 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) Orbitrap 44V, positive-QTOF | splash10-0a4i-9000000000-158d88e5fdd09f1bfc44 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) Orbitrap 53V, positive-QTOF | splash10-0a4i-9000000000-e48e57dbfb8d67f5c722 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) n/a 23V, positive-QTOF | splash10-0a4i-3890000000-dc3e6fa9504ad7732b36 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) n/a 23V, positive-QTOF | splash10-014i-9000000000-fb41d95361a6747c1394 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) n/a 23V, positive-QTOF | splash10-0kps-4910000000-366e65362ec66509aff9 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) n/a 23V, positive-QTOF | splash10-0f79-2910000000-96991d9805c0c30dbaf4 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) n/a 23V, positive-QTOF | splash10-004i-9000000000-2b3b5490150f8c42c1ef | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - MG(0:0/16:0/0:0) 35V, Positive-QTOF | splash10-0a4m-9201000000-1493642eda69722aa926 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - MG(0:0/16:0/0:0) 10V, Positive-QTOF | splash10-0002-0009000000-88db68411e5bedb3a55c | 2017-10-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - MG(0:0/16:0/0:0) 20V, Positive-QTOF | splash10-001k-0009000000-3ea7f1cea75ce9907e95 | 2017-10-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - MG(0:0/16:0/0:0) 40V, Positive-QTOF | splash10-00f2-0049000000-f01e41d62e6fdf3b791b | 2017-10-04 | Wishart Lab | View Spectrum |
|
---|
Disease References | Metastatic melanoma |
---|
- Frankel AE, Coughlin LA, Kim J, Froehlich TW, Xie Y, Frenkel EP, Koh AY: Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients. Neoplasia. 2017 Oct;19(10):848-855. doi: 10.1016/j.neo.2017.08.004. Epub 2017 Sep 15. [PubMed:28923537 ]
| Colorectal cancer |
---|
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
- Wang X, Wang J, Rao B, Deng L: Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals. Exp Ther Med. 2017 Jun;13(6):2848-2854. doi: 10.3892/etm.2017.4367. Epub 2017 Apr 20. [PubMed:28587349 ]
|
|
---|